Paper Details
- Home
- Paper Details
Drug-free Holidays: Compliance, Tolerability, and Acceptability of a 3-Day Atovaquone/Proguanil Schedule for Pretravel Malaria Chemoprophylaxis in Australian Travelers.
Author: Furuya-KanamoriLuis, LauColleen L, MillsDeborah J, MillsLaura C, RamseyLani
Original Abstract of the Article :
Poor compliance with chemoprophylaxis is a major contributing factor to the risk of malaria in travelers. Pre-travel chemoprophylaxis may improve compliance by enabling "drug-free holidays." The standard treatment dose of atovaquone/proguanil (250 mg/100 mg, 4 tablets/day for 3 days) provides protec...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1093/cid/ciy854
データ提供:米国国立医学図書館(NLM)
Navigating the Desert of Malaria Chemoprophylaxis
Malaria is a serious threat, especially for travelers venturing into malaria-prone regions. Ensuring compliance with chemoprophylaxis is crucial to minimizing risk, but finding a balance between protection and travel enjoyment is like finding a pathway through a dense, unforgiving desert. This study delves into the potential of a 3-day atovaquone/proguanil schedule for pre-travel chemoprophylaxis, offering a possible route to 'drug-free holidays'.
The study assessed the compliance, tolerability, and acceptability of a 3-day atovaquone/proguanil regimen for malaria chemoprophylaxis. The researchers discovered that this regimen, providing protection for at least 4 weeks, could potentially be used for pre-travel chemoprophylaxis. This finding could be like discovering a shortcut through the desert, allowing travelers to enjoy their trip without the burden of daily medication.
A Potential Solution for Travelers
The study findings suggest that a 3-day atovaquone/proguanil schedule could be a viable alternative for pre-travel malaria chemoprophylaxis. This finding could potentially improve compliance by enabling 'drug-free holidays', providing a more enjoyable travel experience. This discovery could be like finding a hidden oasis in the desert, offering travelers a chance to relax and enjoy their trip without the constant worry of malaria.
Travel Smart and Stay Safe
The use of a 3-day atovaquone/proguanil schedule for pre-travel malaria chemoprophylaxis could be a promising solution for travelers. However, it is crucial to consult with healthcare professionals for personalized advice and to ensure the suitability of this regimen for individual travelers. Remember, just like navigating a desert, careful planning and preparation are essential to ensure a safe and enjoyable journey.
Dr. Camel's Conclusion
This study sheds light on a promising new approach to malaria chemoprophylaxis, offering travelers a potential 'drug-free holiday' while still ensuring adequate protection. This discovery is like finding a hidden oasis in the desert of malaria prevention, providing a path to safe and enjoyable travel experiences.
Date :
- Date Completed 2020-08-13
- Date Revised 2020-08-13
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.